Concepedia

M. Delforge

MD

3

Publications

116

Citations

3

H-Index

1995

Active since

Affiliations

KU Leuven(Current)

M. Delforge is an author at KU Leuven specializing in health sciences, medicine, and oncology.

Top concepts

HealthMedicineOncologyPathologyHematologyCancer ResearchTransplantationMolecular OncologyRadiation OncologyCancer Epidemiology

Publications per year

1995–2015

3

Publications

3

Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

Jesús F. San Miguel, K. Weisel, Kevin Song et al. · Haematologica · 2015 · 52 citations · Full text

Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single‐dose cyclophosphamide combined with rhGM‐CSF or rhG‐CSF

Hilde Demuynck, M. Delforge, GREGOR VERHOEF et al. · British Journal of Haematology · 1995 · 38 citations

Incidence of second primary malignancy (SPM) in melphalan-prednisone-lenalidomide combination followed by lenalidomide maintenance (MPR-R) in newly diagnosed multiple myeloma patients (pts) age 65 or older.

Antonio Palumbo, M. Delforge, J. Catalano et al. · Journal of Clinical Oncology · 2011 · 26 citations

Mixed-phenotype Acute Leukemia, Pathology, Myeloid Neoplasia +17

Rows per page

1–3 of 3